Through Nov. 15 of last year, pharma deal value rose 79% compared to the same period in 2024, according to Bain. The average deal size also climbed more than 80%, “signaling a decisive return of ...

Find out how NAMs are influencing safety assessments and decision-making in the pharmaceutical industry ahead of 2026.

The guiding principles of good AI practice in drug development are a first step of a renewed EU-US cooperation.

AI: How does this technological revolution fit with the pharmaceutical regulators who oversee the pharmaceutical sector at ...

The industry has learned how the ball bounces—now it must decide where to play next.  | While 2025 was dedicated to “understanding a little bit more about the rules of this game that we’re playing,” ...

BioDlink, a leading global contract development and manufacturing organization (CDMO), has released a white paper titled ...

The global rise of antimicrobial resistance (AMR) among pathogenic microorganisms is widely recognised as one of the most pressing challenges in ...

Background Most minority populations in Europe generally exhibit lower childhood vaccine uptake compared with the general population. Improving uptake in these populations requires contextually ...